596792-36-8

Basic information

• Product Name: L-Phenylalaninamide, 2,6-dimethyl-L-tyrosyl-L-prolyl-L-phenylalanyl-
• CAS NO: 596792-36-8
• Molecular Formula: C34H41N5O5
• Molecular Weight: 599.73
• Mol File: 596792-36-8.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: L-Phenylalaninamide, 2,6-dimethyl-L-tyrosyl-L-prolyl-L-phenylalanyl-(CAS DataBase Reference)
• NIST Chemistry Reference: L-Phenylalaninamide, 2,6-dimethyl-L-tyrosyl-L-prolyl-L-phenylalanyl-(596792-36-8)
• EPA Substance Registry System: L-Phenylalaninamide, 2,6-dimethyl-L-tyrosyl-L-prolyl-L-phenylalanyl-(596792-36-8)

Safety Data

• Hazardous Substances Data: 596792-36-8(Hazardous Substances Data)

Upstream product

• 71989-31-6 Fmoc-Pro-OH 
• 35661-40-6 N-Fmoc L-Phe 
• 579491-05-7 [(S)-2-{(S)-2-[(S)-1-((S)-1-Carbamoyl-2-phenyl-ethylcarbamoyl)-2-phenyl-ethylcarbamoyl]-pyrrolidin-1-yl}-1-(4-hydroxy-2,6-dimethyl-benzyl)-2-oxo-ethyl]-carbamic acid tert-butyl ester 
• 579490-95-2 Boc-Pro-Phe-Phe-NH₂ 
• 80110-73-2 2,6-dimethyl-(S)-tyrosine hydrochloride 
• 73504-61-7 diphenylalaninamide hydrochloride 
• 33900-18-4 Cam-3508 
• 99953-00-1 (S)-N-Boc-2,6-dimethyltyrosine 
• 65864-22-4 (S)-2-amino-3-phenylpropionamide hydrochloride 
• 67729-36-6 Boc-Phe-O-COO-isoBu 
• 88463-18-7 (S)-2-[(tert-butoxycarbonyl)amino]-3-phenylpropionamide 
• 13734-34-4 N-tert-butoxycarbonyl-L-phenylalanine 

Downstream Products

• 1015236-53-9 H-Tyr(2,6-Me₂-3,5-I₂)-Pro-Phe-Phe-NH₂ 

Relevant articles and documents

Biodegradable Amphipathic Peptide Hydrogels as Extended-Release System for Opioid Peptides

Chronic pain is currently treated with opioids that offer unsatisfactory long-term analgesia and produce serious side effects. There is a clear need for alternative therapies. Herein, peptide-based hydrogels are used as extended-release drug delivery carriers. Two different formulations were developed: the drug is coformulated within the hydrogel; the drug is an integral part of the hydrogelator. Both strategies afford a prolonged and significant antinociception up to 72 h after subcutaneous administration in mice.